Not sure this will have to go through phase 1, 2, 3 like a pharma does?
Currently proof of concept - done - and it works. They would likely be able to go straight into a larger confirmation trial.
BTM was able to get TGA and a FDA 510k approval after a free flap donor site trial and a 5 person large TBSA burn trial (obviously with many animal trials prior to these).
- Forums
- ASX - By Stock
- PNV
- Ann: BTM delivers positive First in Man results in Cell Therapies
PNV
polynovo limited
Add to My Watchlist
0.41%
!
$1.21

Ann: BTM delivers positive First in Man results in Cell Therapies, page-71
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.21 |
Change
0.005(0.41%) |
Mkt cap ! $832.4M |
Open | High | Low | Value | Volume |
$1.21 | $1.25 | $1.20 | $205.9K | 168.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 1561 | $1.21 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.22 | 13443 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
14 | 7578 | 1.215 |
11 | 19964 | 1.210 |
9 | 30259 | 1.205 |
13 | 116477 | 1.200 |
6 | 13796 | 1.195 |
Price($) | Vol. | No. |
---|---|---|
1.220 | 34197 | 14 |
1.225 | 13411 | 6 |
1.230 | 30840 | 7 |
1.235 | 84022 | 10 |
1.240 | 32915 | 6 |
Last trade - 10.17am 25/06/2025 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |